Omicia’s Opal Clinical platform helps researchers interpret DNA data

The platform allows hospitals and diagnostic labs to launch genetic studies faster and interpret results more quickly and more accurately.

A company looking to bring genetic medicine to smartphone users

Previously, San Diego-based Illumina managed to drive down the cost of sequencing a human genome to $1,000, and now it's setting sight on a consumer product.